Renal Comorbidity After Solid Organ and Stem Cell Transplantation

被引：25

作者：

Clajus, C. ^{[1
]}

Hanke, N. ^{[1
]}

Gottlieb, J. ^{[2
]}

Stadler, M. ^{[3
]}

Weismueller, T. J. ^{[4
]}

Strassburg, C. P. ^{[4
]}

Broecker, V. ^{[5
]}

Bara, C. ^{[6
]}

Lehner, F. ^{[7
]}

Drube, J. ^{[8
]}

Kielstein, J. T. ^{[1
]}

Schwarz, A. ^{[1
]}

Gueler, F. ^{[1
]}

Haller, H. ^{[1
]}

Schiffer, M. ^{[1
]}

机构：

[1] Hannover Med Sch, Div Nephrol & Hypertens, D-3000 Hannover, Germany

[2] Hannover Med Sch, Div Pulmonol, D-3000 Hannover, Germany

[3] Hannover Med Sch, Div Hematol Hemostasis Oncol & Stem Cell Transpla, D-3000 Hannover, Germany

[4] Hannover Med Sch, Div Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany

[5] Hannover Med Sch, Dept Pathol, D-3000 Hannover, Germany

[6] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, D-3000 Hannover, Germany

[7] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, D-3000 Hannover, Germany

[8] Hannover Med Sch, Dept Pediat Nephrol, Integrated Res & Treatment Ctr Transplantat IFB T, D-3000 Hannover, Germany

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷 / 07期

关键词：

Dialysis; heart transplantation; hemato-poietic stem cell transplantation; kidney transplantation; liver transplantation; lung transplantation; CHRONIC KIDNEY-DISEASE; LIVER-TRANSPLANTATION; CALCINEURIN INHIBITOR; REQUIRING DIALYSIS; CYSTATIN-C; FAILURE; INJURY; PREDICTORS; RECIPIENTS; LUNG;

D O I：

10.1111/j.1600-6143.2012.04047.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

After transplantation of solid organs or hematopoietic stem cells, a significant acute decrease in renal function occurs in the majority of patients. Depending on the degree of kidney injury, a large number of patients develop chronic kidney disease (CKD) and some develop end-stage renal disease requiring renal replacement therapy. The incidence varies depending on the transplanted organ, but important risk factors for the development of CKD are preexisting renal disease, hepatitis C, diabetes, hypertension, age, sex, posttransplant acute kidney injury and thrombotic microangiopathy. This review article focuses on the risk factors of posttransplant chronic kidney disease after organ transplantation, considering the current literature and integrates the incidence and the associated mortality rates of acute and chronic kidney disease. Furthermore, we introduce the RECAST (REnal Comorbidity After Solid organ and hematopoietic stem cell Transplantation) registry.

引用

页码：1691 / 1699

页数：9

共 50 条

[31] Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation
Nagle, Sarah J.
Reshef, Ran
Tsai, Donald E.
CLINICS IN CHEST MEDICINE, 2017, 38 (04) : 771 - +
[32] New Steps in the Use of Mesenchymal Stem Cell in Solid Organ Transplantation
Franquesa M.
Merino A.
Grinyó J.M.
Current Transplantation Reports, 2015, 2 (2) : 184 - 190
[33] Advancement of Mesenchymal Stem Cell Therapy in Solid Organ Transplantation (MISOT)
Hoogduijn, Martin J.
Popp, Felix C.
Grohnert, Anja
Crop, Meindert J.
van Rhijn, Marieke
Rowshani, Ajda T.
Eggenhofer, Elke
Renner, Philipp
Reinders, Marlies E.
Rabelink, Ton J.
van der Laan, Luc J. W.
Dor, Frank J. M. F.
IJzermans, Jan N. M.
Genever, Paul G.
Lange, Claudia
Durrbach, Antoine
Houtgraaf, Jaco H.
Christ, Bruno
Seifert, Martina
Shagidulin, Murat
Donckier, Vincent
Deans, Robert
Ringden, Olle
Perico, Norberto
Remuzzi, Giuseppe
Bartholomew, Amelia
Schlitt, Hans J.
Weimar, Willem
Baan, Carla C.
Dahlke, Marc H.
TRANSPLANTATION, 2010, 90 (02) : 124 - 126
[34] HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOLLOWING SOLID-ORGAN TRANSPLANTATION IN CHILDREN
Riesco, S.
Gonzalez Martinez, B.
Rubio, P. M.
Bueno, D.
Corral, D.
Alonso, T.
Sastre, A.
BONE MARROW TRANSPLANTATION, 2014, 49 : S490 - S491
[35] Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation
Kari Neemann
Alison Freifeld
Current Infectious Disease Reports, 2015, 17
[36] The hematopoietic cell transplantation comorbidity index predicts clinical outcomes after autologous stem cell transplantation
Martinez-Roca, Alexandra
Talarn Forcadell, Carme
Gerardo Rodriguez-Lobato, Luis
Escoda Teigell, Lourdes
Vallansot, Rolando
Cervera Calvo, Marta
Do Nascimento, Janilson
Aguinaco Culebras, Reyes
Gimenez Perez, Teresa
Araguas Arasanz, Carmen
Vicent, Ana
Sola, Maria
Sarra Escarre, Josep
BONE MARROW TRANSPLANTATION, 2018, 53 : 619 - 620
[37] Luminex® and Its Applications for Solid Organ Transplantation, Hematopoietic Stem Cell Transplantation, and Transfusion
Lachmann, Nils
Todorova, Kremena
Schulze, Harald
Schoenemann, Constanze
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (03) : 182 - 189
[38] Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation
Neemann, Kari
Freifeld, Alison
CURRENT INFECTIOUS DISEASE REPORTS, 2015, 17 (07)
[39] Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation
Wareham, Neval E.
Li, Qiuju
Sengelov, Henrik
Da Cunha-Bang, Caspar
Gustafsson, Finn
Heilmann, Carsten
Perch, Michael
Rasmussen, Allan
Sorensen, Soren Schwartz
Mocroft, Amanda
Lundgren, Jens D.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (12) : 3125 - 3135
[40] Hematopoietic stem-cell transplantation following solid-organ transplantation in children
Schechter, T.
Gassas, A.
Weitzman, S.
Grant, D.
Pollock-BarZiv, S.
Dipchand, A.
Alexander, S.
Ali, M.
Avitzur, Y.
Doyle, J.
BONE MARROW TRANSPLANTATION, 2011, 46 (10) : 1321 - 1325

← 1 2 3 4 5 →